Senzime AB

  • Booth: 3630


The Next Generation TOF-monitor. The arm can be tucked under surgical drapes, no thumb access required. Less than 30s start-up, no calibration needed. Ease of use, with single-use electrosensors and no cross-contamination. Precise and reliable information based on EMG-technique. Awaiting FDA Approval. Senzime develops unique patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, during and after surgery. The company's shares are listed on Nasdaq First North (ticker SEZI)


  • Anesthesia Instruments
  • Critical Care Monitoring
  • Medication Safety & Compliance